Published in Blood Weekly, February 7th, 2002
"Human herpesvirus 6 (HHV-6) appears to cause central nervous system (CNS) syndromes, especially in hematopoietic stem cell transplant (HSCT) recipients," according to Danielle M. Zerr and colleagues at the University of Washington and the Fred Hutchinson Cancer Research Center in Seattle.
Ganciclovir and other antiviral agents reduced HHV-6 replication in stem cell recipients although further studies are needed to determine the clinical relevance of these reductions,...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.